Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Node Mapping Versus Sentinel Node Mapping With Systematic Lymphadenectomy in High Risk Endometrial Cancer: a Open Label, Non-inferiority, Randomized Trial.

NCT03366051 is registered in ClinicalTrials.gov with AC Camargo Cancer Center as lead sponsor.

NCT NCT03366051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03366051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Node Mapping Versus Sentinel Node Mapping With Systematic Lymphadenectomy in High Risk Endometrial Cancer: a Open Label, Non-inferiority, Randomized Trial.
Lead sponsor
AC Camargo Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 22, 2017
Completion date
December 20, 2024
Enrollment
178 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, lymph node metastases